Company Number: 14615230

Analysis Date: 2025-07-29 16:27 UTC

Financial Health Assessment of INNOVANK LTD (as at 31 January 2024)

---

1. Financial Health Score: D

Explanation:
The company shows critical signs of financial distress despite being newly incorporated and active. While current assets exceed current liabilities, indicating reasonable short-term liquidity, significant long-term liabilities have pushed net assets and shareholder funds into negative territory. The financial "vital signs" reveal symptoms akin to a patient with stable vital signs but a serious underlying condition that requires immediate intervention.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Current Assets	32,268	Adequate short-term resources ("healthy cash reserves") to cover immediate obligations.
Current Liabilities	1,452	Low short-term debt burden, manageable in the near term.
Net Current Assets	30,816	Positive working capital, indicating the company can pay its short-term bills without strain.
Creditors due after 1 year	55,367	Significant long-term liabilities, a "chronic illness" that burdens financial health.
Net Assets (Equity)	-24,551	Negative net worth—like a weakened immune system, the company’s liabilities outweigh assets severely.
Shareholders' Funds	-24,551	Negative equity signals erosion of capital, indicating financial instability.
Employees	3	Small workforce consistent with micro-entity status, but limited capacity for operations or growth.

---

3. Diagnosis

INNOVANK LTD exhibits a mixed financial condition:

• Positive symptoms: Strong short-term liquidity with net current assets of £30,816 suggests the company can meet immediate financial commitments — akin to a patient with stable vital signs at rest.
• Negative symptoms: The large long-term creditors (£55,367) resulting in negative net assets (-£24,551) and shareholders’ funds are warning signals of underlying financial distress. This situation resembles a chronic condition where debt burden overwhelms the company’s resources, risking insolvency if not managed.
• The company is very young (incorporated January 2023) and may be in early growth or investment stages. However, the negative equity indicates it is currently relying heavily on debt or other liabilities, which could jeopardize ongoing viability if revenue and profitability do not improve.
• The director is the sole significant controller, which centralizes decision-making but may also concentrate risk.

---

4. Recommendations

To improve financial wellness and stabilize the business, the company should consider the following actions:

1. Debt Restructuring or Reduction
   Explore opportunities to renegotiate long-term creditor terms, seek repayment extensions, or convert debt into equity to reduce the burden on net assets.

2. Increase Capital Injection
   The director or investors could inject additional equity capital to restore positive shareholder funds, akin to a "blood transfusion" to strengthen the company’s financial health.

3. Boost Revenue Generation
   Given the retail market activity, focus on increasing sales, improving margins, or expanding customer base to generate positive cash flows and profits.

4. Cost Control and Efficiency
   Tighten operational costs and overheads to improve cash flow and reduce reliance on external funding.

5. Regular Financial Monitoring
   Implement monthly cash flow forecasts and financial reviews to detect emerging symptoms early and respond promptly.

6. Seek Professional Advice
   Consider financial advisory or restructuring expertise to guide through the early signs of distress and plan recovery strategies.

---

Summary

INNOVANK LTD currently maintains adequate short-term liquidity but suffers from a significant long-term debt burden resulting in negative equity. This financial profile signals early distress, demanding urgent corrective measures to restructure liabilities and improve capital strength. With prompt intervention, the company can stabilize and build a healthier financial foundation to support growth.